Traders Unite!

U-Turn Trade Alert: 4/1/2019

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and
neurodegenerative diseases worldwide. The company’s strengths can be seen in multiple areas, such as
its impressive record of earnings per share growth, compelling growth in net income, revenue growth,
largely solid financial position with reasonable debt levels by most measures and notable return on
equity.

Symbol: BIIB
Order: Buy
Price: $240.00
Stop Loss: $216.11
Take Profit: $288.60

No comments yet.

Leave a Reply